Bullish Moving Averages
3
Bearish Moving Averages
13
Back Stocks profile
Stock analysis tool for investors
Performance
Today’s low
66.50Today’s High
67.0052W low
27.2052W High
87.00Open Price
67.00Prev. Close
69.0000Volume
558.00Value
37162.80Fundamentals
Market Cap
10.00
Price to Earnings
8.30
Price to Book Value
0.80
Dividend Yield
0.00
PE to Growth
0.00
Op Revenue TTM
0.00
Net Profit TTM
1.20
Cash From Operating Activity
0.89
Return on Equity %
9.37
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
05 Jul, 2024
98.2
Week
99
Month
99.9
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
66.69
PIVOT
First Resistance
66.89
Second Resistance
67.17
Third Resistance
67.37
First Support
66.41
Second Support
66.21
Third Support
65.93
Relative Strength Index
47.24
Money Flow Index
47.63
MACD
-0.98
MACD Signal
-1.8
Average True Range
3.02
Average Directional Index
28.43
Rate of Change (21)
-3.48
Rate of Change (125)
31.46
Commodity Channel Index
48.9
Williams %R
-32
BETA
1 Month
0.48
3 Month
-0.06
1 Year
-0.56
3 Year
-0.19
PRICE CHANGE ANALYSIS
↑ 0.91%
1 Week
Low
High
62.8
70.5
↓ -3.48%
1 Month
Low
High
56.3
70.5
↓ -10.09%
3 Months
Low
High
56.3
87
↓ -0.6%
6 Months
Low
High
52.25
87
↑ 90.29%
1 Year
Low
High
27.17
87
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 0.25 | 0.70 | 0.46 | 0.43 | -0.10 | 0.19 | 0.59 | -0.38 | 0.13 | 0.36 | 0.19 | |
| Operating Expenses Qtr | 0.09 | 0.02 | 0.02 | 0.05 | 0.02 | 0.02 | 0.05 | 0.11 | 0.18 | 0.08 | 0.07 | |
| Operating Profit Qtr | -0.09 | -0.02 | -0.02 | -0.05 | -0.02 | -0.02 | -0.05 | -0.11 | -0.18 | -0.08 | -0.07 | |
| EBIDT Qtr Cr | 0.15 | 0.68 | 0.44 | 0.38 | -0.24 | 0.17 | 0.54 | -0.50 | 0.21 | 0.28 | 0.12 | |
| Depreciation Qtr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | |
| Net Profit Qtr | -0.29 | 0.68 | 0.44 | 0.38 | -0.15 | 0.16 | 0.53 | -0.50 | 0.14 | 0.28 | 0.11 | |
| Basic EPS Qtr | -1.94 | 4.51 | 2.93 | 2.51 | -0.99 | 1.08 | 3.56 | -3.34 | 0.92 | 1.86 | 0.75 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 1.84 | 0.30 | 0.79 | 0.67 | 1.00 | |
| Operating Expenses Annual Cr | 0.19 | 0.21 | 0.41 | 0.33 | 0.48 | |
| Operating Profit Annual | -0.19 | -0.21 | -0.41 | -0.33 | -0.48 | |
| Operating Profit Margin Annual % | -10.13 | -70.76 | -51.34 | -49.91 | -48.11 | |
| Total Expenses Annual Cr | 0.19 | 0.22 | 0.42 | 0.36 | 0.50 | |
| EBIDT Annual Cr | 1.65 | 0.09 | 0.38 | 0.33 | 0.52 | |
| EBIDT Annual margin % | 89.87 | 29.24 | 48.66 | 50.09 | 51.89 | |
| Depreciation | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | |
| PAT Before ExtraOrdinary Items Annual Cr | 1.20 | 0.05 | 0.56 | 0.25 | 0.42 | |
| Net Profit Annual | 1.20 | 0.05 | 0.56 | 0.25 | 0.42 | |
| Basic EPS Annual | 8.00 | 0.32 | 3.73 | 1.67 | 2.77 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 12.80 | 11.60 | 11.55 | 10.99 | 10.74 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Current Liabilities Annual Cr | 0.18 | 0.02 | 0.11 | 0.06 | 0.22 | |
| Total Capital Plus Liabilities Annual Cr | 13.02 | 11.62 | 11.66 | 11.05 | 10.97 | |
| Fixed Assets Annual | 0.02 | 0.03 | 0.04 | 0.05 | 0.07 | |
| Total Non Current Assets Annual | 6.76 | 5.49 | 5.37 | 0.09 | 2.06 | |
| Total Current Assets Annual | 6.25 | 6.13 | 6.30 | 10.96 | 8.91 | |
| Total Assets Annual | 13.02 | 11.62 | 11.66 | 11.05 | 10.97 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 0.00 | 0.11 | 0.00 | 0.00 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 0.89 | -0.68 | -0.33 | 1.55 | 4.83 | |
| Cash from Investing Activity Annual | -0.69 | 0.63 | 0.97 | 0.51 | 1.01 | |
| Cash from Financing Annual Activity | -0.15 | -0.08 | -2.12 | 0.00 | 0.00 | |
| Net Cash Flow Annual | - | -0.13 | -1.49 | 2.06 | 5.84 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 85.35 | 77.35 | 77.03 | 73.30 | 71.63 | |
| ROE Annual % | 9.37 | 0.40 | 4.84 | 2.27 | 3.86 | |
| ROCE Annual % | 12.80 | 0.63 | 3.15 | 2.82 | 4.59 | |
| Total Debt to Total Equity Annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EBDIT Annual Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Indicator | Graph |
|---|---|
| Total Qtr Revenue cr | |
| Operating Expenses Qtr | |
| Operating Profit Qtr | |
| EBIDT Qtr Cr | |
| Depreciation Qtr | |
| Net Profit Qtr | |
| Basic EPS Qtr |
| Indicator | Mar 2016 | Graph |
|---|---|---|
| Total Revenue Annual | 0.49 | |
| Operating Expenses Annual Cr | 1.84 | |
| Operating Profit Annual | -1.84 | |
| Operating Profit Margin Annual % | -373.84 | |
| Total Expenses Annual Cr | 1.84 | |
| EBIDT Annual Cr | -1.35 | |
| EBIDT Annual margin % | -273.84 | |
| Depreciation | 0.00 | |
| PAT Before ExtraOrdinary Items Annual Cr | -1.45 | |
| Net Profit Annual | -1.45 | |
| Basic EPS Annual | -9.66 |
| Indicator | Mar 2016 | Graph |
|---|---|---|
| Total ShareHolders Funds Annual | 3.67 | |
| Minority Interest Liability Annual Cr | 0.00 | |
| Total Non Current Liabilities Annual Cr | 0.12 | |
| Total Current Liabilities Annual Cr | 0.08 | |
| Total Capital Plus Liabilities Annual Cr | 3.87 | |
| Fixed Assets Annual | 0.00 | |
| Total Non Current Assets Annual | 1.68 | |
| Total Current Assets Annual | 2.19 | |
| Total Assets Annual | 3.87 | |
| Contingent Liabilities plus Commitments Annual Cr | 0.00 |
| Indicator | Mar 2016 | Graph |
|---|---|---|
| Cash from Operating Activity Annual | -2.09 | |
| Cash from Investing Activity Annual | 2.15 | |
| Cash from Financing Annual Activity | 0.00 | |
| Net Cash Flow Annual | 0.06 |
| Indicator | Mar 2016 | Graph |
|---|---|---|
| Book Value Per Share Annual | 24.49 | |
| ROE Annual % | -39.44 | |
| ROCE Annual % | -35.51 | |
| Total Debt to Total Equity Annual | 0.00 | |
| EBDIT Annual Margin % | 0.00 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| SHANTA SOMANI | 3.25 | 74203303 | 0 | 0 |
| CITRIC INDIA LTD | 24.63 | 74203305 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|
| Name | Holding Percent | Holding Id |
|---|---|---|
| RAVINDRA SOMANI | 3.16 | 74203316 |
| SUDHIR HARILAL KALE | 2.33 | 74203317 |
| HUF | 1.09 | 74203310 |
| SHREE CONSULTATION AND SERVICES PVT LTD | 3.63 | 74203313 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 27, 2024 | Audited Results | - |
| Jan 29, 2024 | Quarterly Results & Others | Inter alia, to consider and approve the Re-Appointment of M/s Kavita Khatri & Associates Company Secretaries as a Secretarial Auditor of the Company for the Financial Year 2023-24. |
| Oct 27, 2023 | Quarterly Results | - |
| Jul 27, 2023 | Quarterly Results & Others | - |
| May 24, 2023 | Audited Results | - |
| Jan 31, 2023 | Quarterly Results | - |
| Dec 26, 2022 | Others | Inter alia, 1. To take on record Resignation of Ms.Neha Vora, Company Secretary and Compliance Officer of the Company; |
| Oct 20, 2022 | Quarterly Results | - |
| Jul 28, 2022 | Quarterly Results | - |
| May 27, 2022 | Audited Results | - |
| Jan 28, 2022 | Quarterly Results | - |
| Oct 29, 2021 | Quarterly Results | - |
| Jul 26, 2021 | Quarterly Results & A.G.M. | - |
| May 28, 2021 | Quarterly Results | - |
| Jan 28, 2021 | Quarterly Results | - |
| Oct 19, 2020 | Quarterly Results | - |
| Aug 18, 2020 | Quarterly Results | - |
| Jun 26, 2020 | Audited Results | - |
| Jan 28, 2020 | Quarterly Results | - |
| Oct 22, 2019 | Quarterly Results | - |
| Jul 18, 2019 | Quarterly Results | - |
| May 27, 2019 | Audited Results & A.G.M. | - |
| Jan 28, 2019 | Quarterly Results | - |
| Oct 22, 2018 | Quarterly & Half Yearly Results | - |
| Jul 30, 2018 | Quarterly Results | - |
| May 25, 2018 | Audited Results | - |
| Mar 05, 2018 | Others | To consider appointment of Sachin Sharma & Company, Practicing Company Secretary as Secretarial Auditor of the Company for the Financial Year 2017-2018. |
| Jan 24, 2018 | Quarterly Results & Others | - |
| Oct 18, 2017 | Quarterly Results | - |
| Jul 18, 2017 | Others | - |
| May 22, 2017 | Audited Results & A.G.M | - |
| Jan 23, 2017 | Quarterly Results | - |
| Oct 24, 2016 | Quarterly Results | - |
| Jul 22, 2016 | Quarterly Results | - |
| May 30, 2016 | Audited Results & Others | To consider and approve Board Report under Section 134 of the Companies Act, 2013. |
| Jan 21, 2016 | Quarterly Results & Others | To place and consider Uniform Listing Agreement with SEBI as per the reference to the SEBI. |
| Oct 27, 2015 | Quarterly Results | - |
| Jul 23, 2015 | Quarterly Results & Others | To place and consider the consent letter received from Mr. P. C. Jain for appointment as Additional Director of the Company. |
| May 28, 2015 | Audited Results & Others | 1. To consider and take on record the CEO / CFO Certificate pursuant to Clause 49(V) of the Listing Agreement. 2. To recommend regularisation of Smt.Shanta Somani from Additional Director to Director |
| Mar 16, 2015 | Others | 1.To consider Resignation of Co, Officer of the Co. 2. To place and take on record the consent letter of Mrs. Neha Vora for appointment of Co,Secretary & Compliance Officer of the Company. |
| Jan 20, 2015 | Quarterly Results & Others | To Consider and Appoint M/s. Sarda Soni & Associates as Internal Auditor of the Company pursuant to the requirement of Section 138 of the Companies Act, 2013. |
| Oct 21, 2014 | Quarterly Results | - |
| Sep 26, 2014 | Resignation of Director | To consider and approve the Resignation of Shri. Ashok Joshi from the position of Compliance Officer, Chief Financial Officer and Directorship of the Company. |
| May 23, 2014 | Audited Results & Dividend,Others | 1. To recommend re-appointment of Shri G. K. Joshi, Director of the Company who retires by rotation and, being eligible offers himself for re-appointment. |
| Jan 15, 2014 | Quarterly Results | - |
| Dec 09, 2013 | Others | Appointment & Resignation of Directors |
| Oct 21, 2013 | Quarterly Results | - |
| Jul 26, 2013 | Quarterly Results | - |
| May 22, 2013 | Audited Results & Others | - |
| Apr 30, 2013 | Quarterly Results | - |
| Jan 14, 2013 | Quarterly Results & Others | To place & take on record the Limited Review Report on Un-audited Financial Results for the quarter ended Dec. 31, 2012. and appointments and resignation of directors. |
| Oct 18, 2012 | Quarterly Results | - |
| Jul 18, 2012 | Quarterly Results | - |
| Jun 29, 2012 | Audited Results | - |
| May 04, 2012 | Quarterly Results | - |
| Jan 18, 2012 | Quarterly Results & Others | The Board decided to raise Capital upto Rs. 3 Crs by issue of Shares on Preferential Basis and to seek consent of the Members of Company u/s. 81 (1A) of the Companies Act, 1956. |
| Jul 26, 2011 | Quarterly Results & Others | - |
| Jun 13, 2011 | Audited Results | - |
| May 31, 2011 | Shifting of Registered Office | inter alia to consider shifting of Registered Office of the Company from Plot no. 5 M I D C Kalayan -Bhiwandi Road via Kalyan Thane to another place within the municipal limit of Kalyan. |
| Apr 27, 2011 | Quarterly Results & Others | To consider appointment of Mr. Madhusudan Vyas Director of the Company as CEO of the Company. |
| Ex-Date | Bonus Ratio | Record Date |
|---|
02 Jul 2024
CHEMO PHARMA LABORATORIES LTD. - 506365 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (DP), Regulations, 2018 for the Quarter Ended June 30, 2024
28 Jun 2024
CHEMO PHARMA LABORATORIES LTD. - 506365 - Closure of Trading Window
Intimation of Trading Window closure
10 Jun 2024
CHEMO PHARMA LABORATORIES LTD. - 506365 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding issue of Duplicate Share Certificate under Reg. 39(3) of SEBI (LODR) Regulation, 2015
28 May 2024
CHEMO PHARMA LABORATORIES LTD. - 506365 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of Newspaper Advertisement of Audited Financial Results for the Quarter and Year Ended March 31, 2024 of the Company
27 May 2024
CHEMO PHARMA LABORATORIES LTD. - 506365 - Appointment Of M/S. Sarda Soni Associates LLP As An Internal Auditor For The Financial Year 2024-2025
Appointment of M/S Sarda Soni Associates LLP as an Internal Auditor for the Financial Year 2024-2025
27 May 2024
CHEMO PHARMA LABORATORIES LTD. - 506365 - Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2024
Audited Financial Results of the Company for the Quarter and Year Ended March 31, 2024
27 May 2024
CHEMO PHARMA LABORATORIES LTD. - 506365 - Board Meeting Outcome for Outcome Of The Board Meeting Held On Monday, May 27, 2024
Outcome Of The Board Meeting Held On Monday, May 27, 2024
15 May 2024
CHEMO PHARMA LABORATORIES LTD. - 506365 - Declaration Of Non-Applicability Of Regulation 23(9) Of SEBI (LODR) Regulation, 2015
Declaration of Non-Applicability of Regulation 23(9) of SEBI (LODR) Regulation, 2015 for the half year ended March 31, 2024
10 May 2024
CHEMO PHARMA LABORATORIES LTD. - 506365 - Board Meeting Intimation for Board Meeting To Be Held On Monday, May 27, 2024
CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2024 ,inter alia, to consider and approve the following business: 1. To consider and approve the Audited Financial Results for the quarter and year ended March 31, 2024 along with the Auditor's Report thereon. 2. To consider appointment of M/s Sarda Soni & Associates as Internal Auditor of the Company for the financial year 2024-25
07 May 2024
CHEMO PHARMA LABORATORIES LTD. - 506365 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding issue of Dublicate Share Certificate under Regulation 39(3) of SEBI (LODR) Regulations, 2015
